ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs

  When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.

• End-To-End Inventory Control Supports Biotech's Expanding Portfolio

  Many organizations struggle with siloed operations, but this modern GxP inventory solution solves these challenges by providing a centralized, cloud-based platform for end-to-end visibility.

• Running Decentralized Trials At Scale

  Sponsors are recognizing the potential benefits of decentralized clinical trials, including reduced operational costs and improved recruitment and retention of more diverse patient populations.

• How Modern Software Architecture Is Revolutionizing IRT Solutions

  Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.

• Transportation Solutions For Cell And Gene Therapy Supply Chains

  Developing a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.

• Ensuring On-Time Release Of CAR-T Cell Treatment In Spain

  Due to the COVID-19 pandemic, and the start of Brexit, a CAR-T cell treatment therapy shipment was offloaded multiple times by the airline, requiring an alternative transport solution.

• Choosing RTSM? Evaluate The Team Running It, Not Just The Software

  High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.

• Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials

  Evaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.

• Why Advanced cGMP Manufacturing Is Key to Pharma Success

  Advanced cGMP facilities deliver control, expertise, and reliable processes that protect quality and support smooth progress to market. Strong partnerships help reduce risk in complex programs.

• Avoiding The Risk Of A Non-Transparent Clinical Supply Solution

  With the supply chain and transportation logistics disruption caused by the COVID-19 pandemic, full documentation and complete transparency becomes even more important to avoid delays and assert provenance.